Fecal microRNA profile in patients with colorectal carcinoma before and after curative surgery

International Journal of Colorectal Disease

Volumn 30, Issue 7, 2015, Pages 891-898

  Rotelli, M T ^a   Di Lena, M ^a   Cavallini, A ^b   Lippolis, C ^b   Bonfrate, L ^a   Chetta, N ^a   Portincasa, P ^a   Altomare, D F ^a  

^a UNIVERSITY OF BARI   (Italy)

^b IRRCS De Bellis   (Italy)

Author keywords

Colorectal cancer; Fecal microRNA; Follow up; Screening

Indexed keywords

MEMBRANE PROTEIN; MICRORNA; MICRORNA 141; MIR 16 3P; MIR 20A 5P; MIR 21 3P; RNU6B PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SURGERY; CANCER TISSUE; CLINICAL ARTICLE; COLON MUCOSA; COLONOSCOPY; COLORECTAL CARCINOMA; CONTROLLED STUDY; FECES ANALYSIS; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECONDARY PREVENTION; TUMOR BIOPSY; VERY ELDERLY; CASE CONTROL STUDY; CHEMISTRY; COLORECTAL NEOPLASMS; COLORECTAL SURGERY; DEMOGRAPHY; FECES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; INTESTINE MUCOSA; METABOLISM; PATHOLOGY; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; RNA STABILITY;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; COLORECTAL SURGERY; DEMOGRAPHY; FECES; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTESTINAL MUCOSA; MALE; MICRORNAS; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RNA STABILITY; ROC CURVE;

EID: 84931570602     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-015-2248-0     Document Type: Article

References (32)

1. Krol J, Loedige I, Filipowicz W (2010) The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 11:597–610. doi:10.1038/nrg2843
2. Wu WK, Law PT, Lee CW et al (2011) MicroRNA in colorectal cancer: from benchtop to bedside. Carcinogenesis 32:247–253. doi:10.1093/carcin/bgq243
3. Dong Y, Wu WK, Wu CW, Sung JJ, Yu J, Ng SS (2011) MicroRNA dysregulation in colorectal cancer: a clinical perspective. Br J Cancer 104:893–898. doi:10.1038/bjc.2011.57
4. Bonfrate L, Altomare DF, Di Lena M et al (2013) MicroRNA in colorectal cancer: new perspectives for diagnosis, prognosis and treatment. J Gastrointestin Liver Dis 22:311–320
5. Agostini M, Pucciarelli S, Calore F, Bedin C, Enzo M, Nitti D (2010) miRNAs in colon and rectal cancer: a consensus for their true clinical value. Clin Chim Acta 411:1181–1186. doi:10.1016/j.cca.2010.05.002
6. Volinia S, Calin GA, Liu CG et al (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 103:2257–2261
7. Faber C, Kirchner T, Hlubek F (2009) The impact of microRNAs on colorectal cancer. Virchows Arch 454:359–367
8. Schee K, Boye K, Abrahamsen TW, Fodstad O, Flatmark K (2012) Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer. BMC Cancer 12:505. doi:10.1186/1471-2407-12-505
9. Nugent M, Miller N, Kerin MJ (2011) MicroRNAs in colorectal cancer: function, dysregulation and potential as novel biomarkers. Eur J Surg Oncol 37:649–654. doi:10.1016/j.ejso.2011.05.005
10. Schetter AJ, Okayama H, Harris CC (2012) The role of microRNAs in colorectal cancer. Cancer J 18:244–252
11. Mazeh H, Mizrahi I, Ilyayev N et al (2013) The diagnostic and prognostic role of microRNA in colorectal cancer—a comprehensive review. J Cancer 4:281–295. doi:10.7150/jca.5836
12. Wang Q, Huang Z, Ni S et al (2012) Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer. PLoS One 7, e44398. doi:10.1371/journal.pone.0044398
13. Ye JJ, Cao J (2014) MicroRNAs in colorectal cancer as markers and targets: recent advances. World J Gastroenterol 20:4288–4299. doi:10.3748/wjg.v20.i15.4288
14. Patel RS, Jakymiw A, Yao B et al (2011) High resolution of microRNA signatures in human whole saliva. Arch Oral Biol 56:1506–1513. doi:10.1016/j.archoralbio.2011.05.015
15. Wang G, Chan ES, Kwan BC et al (2012) Expression of microRNAs in the urine of patients with bladder cancer. Clin Genitourin Cancer 10:106–113. doi:10.1016/j.clgc.2012.01.001
16. Roth C, Rack B, Muller V, Janni W, Pantel K, Schwarzenbach H (2010) Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer. Breast Cancer Res 12:R90. doi:10.1186/bcr2766
17. Di Lena M, Travaglio E, Altomare DF (2013) New strategies for colorectal cancer screening. World J Gastroenterol 19:1855–1860. doi:10.3748/wjg.v19.i12.1855
18. Ahmed FE, Ahmed NC, Vos PW et al (2013) Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle. Cancer Genomics Proteomics 10:93–113
19. Link A, Balaguer F, Shen Y et al (2010) Fecal microRNAs as novel biomarkers for colon cancer screening. Cancer Epidemiol Biomarkers Prev 19:1766–1774. doi:10.1158/1055-9965.EPI-10-0027
20. Koga Y, Yasunaga M, Takahashi A et al (2010) MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening. Cancer Prev Res (Phila) 3:1435–1442. doi:10.1158/1940-6207.CAPR-10-0036
21. Wu CW, Ng SS, Dong YJ et al (2012) Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps. Gut 61:739–745. doi:10.1136/gut.2011.239236
22. Wang WT, Zhao YN, Yan JX et al (2014) Differentially expressed microRNAs in the serum of cervical squamous cell carcinoma patients before and after surgery. J Hematol Oncol 7:6. doi:10.1186/1756-8722-7-6
23. Le HB, Zhu WY, Chen DD et al (2012) Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients. Med Oncol 29:3190–3197. doi:10.1007/s12032-012-0303-z
24. Ng EK, Chong WW, Jin H et al (2009) Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 58:1375–1381. doi:10.1136/gut.2008.167817
25. de Krijger I, Mekenkamp LJ, Punt CJ, Nagtegaal ID (2011) MicroRNAs in colorectal cancer metastasis. J Pathol 224:438–447. doi:10.1002/path.2922
26. Koga Y, Yamazaki N, Yamamoto Y et al (2013) Fecal miR-106a is a useful marker for colorectal cancer patients with false-negative results in immunochemical fecal occult blood test. Cancer Epidemiol Biomarkers Prev 22:1844–1852. doi:10.1158/1055-9965.EPI-13-0512
27. Yamazaki N, Koga Y, Yamamoto S et al (2013) Application of the fecal microRNA test to the residuum from the fecal occult blood test. Jpn J Clin Oncol 43:726–733. doi:10.1093/jjco/hyt068
28. Pigati L, Yaddanapudi SC, Iyengar R et al (2010) Selective release of microRNA species from normal and malignant mammary epithelial cells. PLoS One 5, e13515. doi:10.1371/journal.pone.0013515
29. Dawson B, Trapp RG (2001) Basic & clinical biostatistics. McGraw-Hill, New York
30. Kalimutho M, Del Vecchio Blanco G, Di Cecilia S et al (2011) Differential expression of miR-144* as a novel fecal-based diagnostic marker for colorectal cancer. J Gastroenterol 46:1391–1402. doi:10.1007/s00535-011-0456-0
31. Li JM, Zhao RH, Li ST et al (2012) Down-regulation of fecal miR-143 and miR-145 as potential markers for colorectal cancer. Saudi Med J 33:24–29
32. Phua LC, Chue XP, Koh PK, Cheah PY, Chan EC, Ho HK (2014) Global fecal microRNA profiling in the identification of biomarkers for colorectal cancer screening among Asians. Oncol Rep 32:97–104. doi:10.3892/or.2014.3193